Opposing functions have been identified, since some studies reported that IL-1β and IL-18 production contributes to intestinal inflammation; meanwhile, other reports have suggested that the production of IL-1β and IL-18 induced by the NLRP3 inflammasome protects against colitis and colitis-associated tumorigenesis [29,30,31]. Here, NLRP3 is linked to colitis.